Abstract
VIM-39, a VIM-1-like metallo-β-lactamase variant (VIM-1 Thr33Ala His224Leu) was identified in a clinical isolate of Klebsiella pneumoniae belonging to sequence type 147. VIM-39 hydrolyzed ampicillin, cephalothin, and imipenem more efficiently than did VIM-1 and VIM-26 (a VIM-1 variant with the His224Leu substitution) because of higher turnover rates.
Cite
CITATION STYLE
Papagiannitsis, C. C., Pollini, S., De Luca, F., Rossolini, G. M., Docquier, J. D., & Hrabák, J. (2015). Biochemical characterization of VIM-39, a VIM-1-like metallo-β-lactamase variant from a multidrug-resistant Klebsiella pneumoniae isolate from Greece. Antimicrobial Agents and Chemotherapy, 59(12), 7811–7814. https://doi.org/10.1128/AAC.01935-15
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.